Shareholders’ Equity |
12 Months Ended |
|---|---|
Aug. 31, 2026 | |
| Equity [Abstract] | |
| Shareholders’ Equity |
Note 7 — Shareholders’ Equity
Ordinary Share— The Company is authorized to issue ordinary shares with $ par value. On August 29, 2025, the Company agreed to issue Founder Shares to the Sponsor for an aggregate purchase price of $, or $ per share. Such ordinary shares were subsequently issued to the Sponsor on September 4, 2025. In January 2026, the Company entered into an amendment to the subscription agreement with the Sponsor for the purchase of an additional ordinary shares, resulting in a total acquisition of ordinary shares for an aggregated consideration of $, or approximately $ per ordinary share.
As of August 31, 2026, there were Founder Shares, Representative Shares, and Private Shares issued and outstanding (excluding shares subject to possible redemption). As of August 31, 2025, there were Founder Shares outstanding. Founder Shares have been retroactively restated to reflect an amendment to the Subscription Agreement mentioned above.
Rights — Except in cases where the Company is not the surviving company in a business combination, each holder of a right will receive one-fourth (1/4) of an ordinary share upon consummation of the initial business combination. In the event the Company will not be the surviving company upon completion of its initial business combination, each holder of a right will be required to affirmatively convert his, her or its rights in order to receive the one-fourth (1/4) of a share underlying each right upon consummation of the business combination unless otherwise waived in the course of the business combination. No fractional shares will be issued upon exchange of rights. No additional consideration will be required to be paid by a holder of rights in order to receive its additional shares upon consummation of a business combination. Fractional shares will be rounded down to the nearest whole share.
If the Company is unable to complete an initial Business Combination within the required time period and the Company liquidates the funds held in the Trust Account, holders of rights will not receive any such funds with respect to their rights, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such rights, and the rights will expire worthless. As of August 31, 2026, there were rights outstanding, consisting of public rights and private rights. As of August 31, 2025, there were rights outstanding.
|